ALKERMES PLC (ALKS) Stock Fundamental Analysis

NASDAQ:ALKS • IE00B56GVS15

29.71 USD
-0.39 (-1.3%)
Last: Mar 2, 2026, 10:45 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

6

ALKS gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 520 industry peers in the Biotechnology industry. ALKS scores excellent points on both the profitability and health parts. This is a solid base for a good stock. ALKS is not valued too expensively and it also shows a decent growth rate. These ratings would make ALKS suitable for quality investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • In the past year ALKS was profitable.
  • In the past year ALKS had a positive cash flow from operations.
  • In multiple years ALKS reported negative net income over the last 5 years.
  • In the past 5 years ALKS always reported a positive cash flow from operatings.
ALKS Yearly Net Income VS EBIT VS OCF VS FCFALKS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M

1.2 Ratios

  • ALKS's Return On Assets of 9.72% is amongst the best of the industry. ALKS outperforms 93.65% of its industry peers.
  • The Return On Equity of ALKS (13.28%) is better than 94.04% of its industry peers.
  • The Return On Invested Capital of ALKS (10.90%) is better than 94.42% of its industry peers.
  • ALKS had an Average Return On Invested Capital over the past 3 years of 18.21%. This is in line with the industry average of 17.87%.
  • The last Return On Invested Capital (10.90%) for ALKS is well below the 3 year average (18.21%), which needs to be investigated, but indicates that ALKS had better years and this may not be a problem.
Industry RankSector Rank
ROA 9.72%
ROE 13.28%
ROIC 10.9%
ROA(3y)14.74%
ROA(5y)6.76%
ROE(3y)22.64%
ROE(5y)9.68%
ROIC(3y)18.21%
ROIC(5y)N/A
ALKS Yearly ROA, ROE, ROICALKS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20

1.3 Margins

  • ALKS has a better Profit Margin (16.37%) than 92.12% of its industry peers.
  • The Operating Margin of ALKS (17.21%) is better than 93.27% of its industry peers.
  • With an excellent Gross Margin value of 86.69%, ALKS belongs to the best of the industry, outperforming 88.85% of the companies in the same industry.
  • ALKS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 17.21%
PM (TTM) 16.37%
GM 86.69%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.55%
GM growth 5Y0.92%
ALKS Yearly Profit, Operating, Gross MarginsALKS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. Health

2.1 Basic Checks

  • ALKS has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • Compared to 1 year ago, ALKS has more shares outstanding
  • Compared to 5 years ago, ALKS has more shares outstanding
  • ALKS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ALKS Yearly Shares OutstandingALKS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
ALKS Yearly Total Debt VS Total AssetsALKS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.2 Solvency

  • ALKS has an Altman-Z score of 5.65. This indicates that ALKS is financially healthy and has little risk of bankruptcy at the moment.
  • ALKS's Altman-Z score of 5.65 is fine compared to the rest of the industry. ALKS outperforms 73.65% of its industry peers.
  • There is no outstanding debt for ALKS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 5.65
ROIC/WACC1.39
WACC7.86%
ALKS Yearly LT Debt VS Equity VS FCFALKS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B

2.3 Liquidity

  • ALKS has a Current Ratio of 3.55. This indicates that ALKS is financially healthy and has no problem in meeting its short term obligations.
  • ALKS has a Current ratio of 3.55. This is comparable to the rest of the industry: ALKS outperforms 41.73% of its industry peers.
  • A Quick Ratio of 3.19 indicates that ALKS has no problem at all paying its short term obligations.
  • With a Quick ratio value of 3.19, ALKS is not doing good in the industry: 60.58% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 3.55
Quick Ratio 3.19
ALKS Yearly Current Assets VS Current LiabilitesALKS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • The earnings per share for ALKS have decreased strongly by -34.90% in the last year.
  • Measured over the past years, ALKS shows a very strong growth in Earnings Per Share. The EPS has been growing by 34.43% on average per year.
  • The Revenue has decreased by -5.25% in the past year.
  • Measured over the past years, ALKS shows a small growth in Revenue. The Revenue has been growing by 7.28% on average per year.
EPS 1Y (TTM)-34.9%
EPS 3Y77.08%
EPS 5Y34.43%
EPS Q2Q%-56.19%
Revenue 1Y (TTM)-5.25%
Revenue growth 3Y9.9%
Revenue growth 5Y7.28%
Sales Q2Q%-10.57%

3.2 Future

  • The Earnings Per Share is expected to grow by 8.40% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 10.44% on average over the next years. This is quite good.
EPS Next Y-20.69%
EPS Next 2Y-9.41%
EPS Next 3Y3.97%
EPS Next 5Y8.4%
Revenue Next Year23.02%
Revenue Next 2Y12.82%
Revenue Next 3Y10.55%
Revenue Next 5Y10.44%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALKS Yearly Revenue VS EstimatesALKS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 1B 2B 3B
ALKS Yearly EPS VS EstimatesALKS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 1 2 3 4

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • ALKS is valuated correctly with a Price/Earnings ratio of 15.72.
  • Based on the Price/Earnings ratio, ALKS is valued cheaply inside the industry as 95.19% of the companies are valued more expensively.
  • The average S&P500 Price/Earnings ratio is at 27.07. ALKS is valued slightly cheaper when compared to this.
  • ALKS is valuated rather expensively with a Price/Forward Earnings ratio of 19.84.
  • Based on the Price/Forward Earnings ratio, ALKS is valued cheaply inside the industry as 93.08% of the companies are valued more expensively.
  • ALKS's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 28.05.
Industry RankSector Rank
PE 15.72
Fwd PE 19.84
ALKS Price Earnings VS Forward Price EarningsALKS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ALKS is valued cheaper than 95.00% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, ALKS is valued cheaper than 97.88% of the companies in the same industry.
Industry RankSector Rank
P/FCF 10.21
EV/EBITDA 14.88
ALKS Per share dataALKS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • The decent profitability rating of ALKS may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.46
EPS Next 2Y-9.41%
EPS Next 3Y3.97%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for ALKS!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ALKERMES PLC

NASDAQ:ALKS (3/2/2026, 10:45:00 AM)

29.71

-0.39 (-1.3%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-25
Earnings (Next)04-29
Inst Owners105.82%
Inst Owner Change2.02%
Ins Owners1.48%
Ins Owner Change6.38%
Market Cap4.91B
Revenue(TTM)1.48B
Net Income(TTM)241.66M
Analysts80.87
Price Target44.69 (50.42%)
Short Float %11.74%
Short Ratio10.15
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)48.47%
Min EPS beat(2)37.11%
Max EPS beat(2)59.84%
EPS beat(4)4
Avg EPS beat(4)45.33%
Min EPS beat(4)12.02%
Max EPS beat(4)72.36%
EPS beat(8)5
Avg EPS beat(8)22.16%
EPS beat(12)8
Avg EPS beat(12)29.21%
EPS beat(16)11
Avg EPS beat(16)142.72%
Revenue beat(2)1
Avg Revenue beat(2)3.62%
Min Revenue beat(2)-1.27%
Max Revenue beat(2)8.51%
Revenue beat(4)2
Avg Revenue beat(4)4.55%
Min Revenue beat(4)-1.27%
Max Revenue beat(4)12.13%
Revenue beat(8)3
Avg Revenue beat(8)2.68%
Revenue beat(12)6
Avg Revenue beat(12)3.44%
Revenue beat(16)9
Avg Revenue beat(16)2.77%
PT rev (1m)0.29%
PT rev (3m)0.57%
EPS NQ rev (1m)-1.13%
EPS NQ rev (3m)-3.14%
EPS NY rev (1m)-0.46%
EPS NY rev (3m)-0.83%
Revenue NQ rev (1m)0.49%
Revenue NQ rev (3m)0.87%
Revenue NY rev (1m)0.07%
Revenue NY rev (3m)0.2%
Valuation
Industry RankSector Rank
PE 15.72
Fwd PE 19.84
P/S 3.32
P/FCF 10.21
P/OCF 9.42
P/B 2.7
P/tB 2.83
EV/EBITDA 14.88
EPS(TTM)1.89
EY6.36%
EPS(NY)1.5
Fwd EY5.04%
FCF(TTM)2.91
FCFY9.79%
OCF(TTM)3.15
OCFY10.62%
SpS8.94
BVpS11.02
TBVpS10.51
PEG (NY)N/A
PEG (5Y)0.46
Graham Number21.65
Profitability
Industry RankSector Rank
ROA 9.72%
ROE 13.28%
ROCE 13.07%
ROIC 10.9%
ROICexc 15.63%
ROICexgc 16.66%
OM 17.21%
PM (TTM) 16.37%
GM 86.69%
FCFM 32.55%
ROA(3y)14.74%
ROA(5y)6.76%
ROE(3y)22.64%
ROE(5y)9.68%
ROIC(3y)18.21%
ROIC(5y)N/A
ROICexc(3y)43.15%
ROICexc(5y)N/A
ROICexgc(3y)50.12%
ROICexgc(5y)N/A
ROCE(3y)21.84%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.55%
GM growth 5Y0.92%
F-Score6
Asset Turnover0.59
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 148.79%
Cap/Sales 2.74%
Interest Coverage 250
Cash Conversion 185.24%
Profit Quality 198.76%
Current Ratio 3.55
Quick Ratio 3.19
Altman-Z 5.65
F-Score6
WACC7.86%
ROIC/WACC1.39
Cap/Depr(3y)110.09%
Cap/Depr(5y)83%
Cap/Sales(3y)2.59%
Cap/Sales(5y)2.72%
Profit Quality(3y)136.19%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-34.9%
EPS 3Y77.08%
EPS 5Y34.43%
EPS Q2Q%-56.19%
EPS Next Y-20.69%
EPS Next 2Y-9.41%
EPS Next 3Y3.97%
EPS Next 5Y8.4%
Revenue 1Y (TTM)-5.25%
Revenue growth 3Y9.9%
Revenue growth 5Y7.28%
Sales Q2Q%-10.57%
Revenue Next Year23.02%
Revenue Next 2Y12.82%
Revenue Next 3Y10.55%
Revenue Next 5Y10.44%
EBIT growth 1Y-39.68%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year63.82%
EBIT Next 3Y28.61%
EBIT Next 5Y30.01%
FCF growth 1Y18.41%
FCF growth 3YN/A
FCF growth 5Y63.91%
OCF growth 1Y18.59%
OCF growth 3Y191.61%
OCF growth 5Y44.45%

ALKERMES PLC / ALKS FAQ

What is the fundamental rating for ALKS stock?

ChartMill assigns a fundamental rating of 6 / 10 to ALKS.


What is the valuation status of ALKERMES PLC (ALKS) stock?

ChartMill assigns a valuation rating of 6 / 10 to ALKERMES PLC (ALKS). This can be considered as Fairly Valued.


Can you provide the profitability details for ALKERMES PLC?

ALKERMES PLC (ALKS) has a profitability rating of 7 / 10.


Can you provide the expected EPS growth for ALKS stock?

The Earnings per Share (EPS) of ALKERMES PLC (ALKS) is expected to decline by -20.69% in the next year.